Ayala Pharmaceuticals Inc FAD.BE
€0.23 €0.11 (32.37%) 1D
Last Updated: May 13, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Ayala Pharmaceuticals Inc Stock Halal?
Shariah Compliance Analysis of FAD.BE Stock
Germany Health Care Nano Cap No. As of September 2026, Ayala Pharmaceuticals Inc (FAD.BE) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Ayala Pharmaceuticals Inc does not pass Musaffa's business and financial screening criteria.
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. The company is headquartered in Monmouth Junction, New Jersey and currently employs 20 full-time employees. The company went IPO on 2005-07-28. The firm's lead candidate is aspacytarabine (BST-236), a novel anti-metabolite for first line treatment in unfit acute myeloid leukemia (AML). Aspacytarabine (BST-236) is composed of cytarabine covalently bound to asparagine, acting as a pro-drug of cytarabine.
FAD.BE Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Ayala Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Ayala Pharmaceuticals Inc (FAD.BE) Chart
Financial Metrics & Statements of Ayala Pharmaceuticals Inc (FAD.BE)
FAQ's for Ayala Pharmaceuticals Inc (FAD.BE)
- As of September 2026, Ayala Pharmaceuticals Inc FAD.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ayala Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Ayala Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Ayala Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Ayala Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Ayala Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Ayala Pharmaceuticals Inc (FAD.BE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
